DK1786439T3 - Fremgangsmåder til aktivering af NKT-celler - Google Patents

Fremgangsmåder til aktivering af NKT-celler

Info

Publication number: DK1786439T3
Authority: DK; Denmark
Prior art keywords: methods; nkt cell; activating; nkt cells; activating nkt
Prior art date: 2004-09-03

Application number

DK05810863.0T

Other languages

English (en)

Inventor

Albert Bendelac

Luc Teyton

Paul Savage

Dapeng Zhou

Original Assignee

Univ Chicago

Scripps Research Inst

Univ Brigham Young

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-09-03

Filing date

2005-09-02

Publication date

2010-07-12

2005-09-02 Application filed by Univ Chicago, Scripps Research Inst, Univ Brigham Young filed Critical Univ Chicago

2010-07-12 Application granted granted Critical

2010-07-12 Publication of DK1786439T3 publication Critical patent/DK1786439T3/da

Links

210000000581 natural killer T-cell Anatomy 0.000 title abstract 7
230000003213 activating effect Effects 0.000 title abstract 3
JMENXJYBCQFIRK-KRJDXUSZSA-N N-hexacosanoylisoglobotriaosyl ceramide Chemical compound O[C@@H]1[C@@H](O)[C@H](OC[C@H](NC(=O)CCCCCCCCCCCCCCCCCCCCCCCCC)[C@H](O)\C=C\CCCCCCCCCCCCC)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@@H](CO)O1 JMENXJYBCQFIRK-KRJDXUSZSA-N 0.000 abstract 2
102000004127 Cytokines Human genes 0.000 abstract 1
108090000695 Cytokines Proteins 0.000 abstract 1
239000002458 cell surface marker Substances 0.000 abstract 1
230000035755 proliferation Effects 0.000 abstract 1
230000028327 secretion Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/739—Lipopolysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0646—Natural killers cells [NK], NKT cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/90—Polysaccharides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Cell Biology (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Biochemistry (AREA)
Communicable Diseases (AREA)
Transplantation (AREA)
Oncology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

DK05810863.0T 2004-09-03 2005-09-02 Fremgangsmåder til aktivering af NKT-celler DK1786439T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US60694104P	2004-09-03	2004-09-03
PCT/US2005/031407 WO2006029010A2 (en)	2004-09-03	2005-09-02	Methods of activating nkt cells

Publications (1)

Publication Number	Publication Date
DK1786439T3 true DK1786439T3 (da)	2010-07-12

Family

ID=35945148

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05810863.0T DK1786439T3 (da)	2004-09-03	2005-09-02	Fremgangsmåder til aktivering af NKT-celler

Country Status (10)

Country	Link
US (2)	US7998739B2 (da)
EP (1)	EP1786439B1 (da)
JP (1)	JP5005541B2 (da)
AT (1)	ATE464056T1 (da)
AU (1)	AU2005282684B9 (da)
CA (1)	CA2578052C (da)
DE (1)	DE602005020643D1 (da)
DK (1)	DK1786439T3 (da)
ES (1)	ES2344740T3 (da)
WO (1)	WO2006029010A2 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7645873B2 (en)	2003-03-20	2010-01-12	The Scripps Research Institute	6″-amino-6″-deoxygalactosylceramides
DK1786439T3 (da) *	2004-09-03	2010-07-12	Univ Chicago	Fremgangsmåder til aktivering af NKT-celler
DK1848813T3 (da)	2005-01-28	2013-07-15	Univ Brigham Young	Aktivering af bakterielt glycolipid fra CD1D-begrænsede NKT-celler
WO2007118234A2 (en)	2006-04-07	2007-10-18	The Scripps Research Institute	Modified -galactosyl ceramides for staining and stimulating natural killer t cells
AU2007269299B2 (en) *	2006-06-30	2013-01-17	Brigham Young University	Adjuvants and methods of use
WO2008133983A1 (en) *	2007-04-25	2008-11-06	Immurx, Inc.	Adjuvant combinations of nkt activator, cd40 agonist, and optional antigen, the use through inducing synergistic cellular immunity
US8916164B2 (en) *	2007-08-29	2014-12-23	Abivax	Methods of enhancing adjuvaticity of vaccine compositions
EP2058011A1 (en) *	2007-11-07	2009-05-13	Wittycell	Nkt cell activating gycolipids covalently bound antigens and/or drug
EP2060252A1 (en)	2007-11-19	2009-05-20	Wittycell	New formulation of galactosylceramide derivatives
BRPI0820960B8 (pt)	2007-12-05	2021-05-25	Abivax	composição, composição farmacêutica, e uso da composição
US9220767B2 (en) *	2008-10-08	2015-12-29	Abivax	Vaccine composition for use against influenza
US9623083B2 (en)	2011-08-30	2017-04-18	Cornell University	Method to screen for an activator of adipose-resident NK cells
GB201506642D0 (en)	2015-04-20	2015-06-03	Ucl Business Plc	T cell receptor
GB201617716D0 (en)	2016-10-19	2016-11-30	Ucl Business Plc	Cell
GB201617714D0 (en)	2016-10-19	2016-11-30	Ucl Business Plc	T Cell receptor
AU2018227801B2 (en) *	2017-02-28	2024-02-22	Research Institute At Nationwide Children's Hospital	PM21 particles to improve bone marrow homing of NK cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1520583B1 (en)	1997-04-10	2009-01-28	Kyowa Hakko Kirin Co., Ltd.	NKT cell-activating agents containing alpha-glycosylceramides
AU2002327338A1 (en) *	2001-07-25	2003-02-17	New York University	Use of glycosylceramides as adjuvants for vaccines against infections and cancer
WO2003105769A2 (en) *	2002-06-13	2003-12-24	New York University	Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases
DK1786439T3 (da) *	2004-09-03	2010-07-12	Univ Chicago	Fremgangsmåder til aktivering af NKT-celler

2005
- 2005-09-02 DK DK05810863.0T patent/DK1786439T3/da active
- 2005-09-02 US US11/218,906 patent/US7998739B2/en not_active Expired - Fee Related
- 2005-09-02 DE DE602005020643T patent/DE602005020643D1/de not_active Expired - Lifetime
- 2005-09-02 CA CA2578052A patent/CA2578052C/en not_active Expired - Fee Related
- 2005-09-02 ES ES05810863T patent/ES2344740T3/es not_active Expired - Lifetime
- 2005-09-02 JP JP2007530414A patent/JP5005541B2/ja not_active Expired - Fee Related
- 2005-09-02 AT AT05810863T patent/ATE464056T1/de not_active IP Right Cessation
- 2005-09-02 EP EP05810863A patent/EP1786439B1/en not_active Expired - Lifetime
- 2005-09-02 AU AU2005282684A patent/AU2005282684B9/en not_active Ceased
- 2005-09-02 WO PCT/US2005/031407 patent/WO2006029010A2/en not_active Ceased
2010
- 2010-10-11 US US12/901,971 patent/US20110082106A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1786439A2 (en)	2007-05-23
CA2578052C (en)	2013-08-13
CA2578052A1 (en)	2006-03-16
US7998739B2 (en)	2011-08-16
AU2005282684A1 (en)	2006-03-16
JP2008512093A (ja)	2008-04-24
AU2005282684B2 (en)	2011-03-10
EP1786439B1 (en)	2010-04-14
ATE464056T1 (de)	2010-04-15
AU2005282684B9 (en)	2011-07-07
ES2344740T3 (es)	2010-09-06
US20060073118A1 (en)	2006-04-06
US20110082106A1 (en)	2011-04-07
DE602005020643D1 (de)	2010-05-27
JP5005541B2 (ja)	2012-08-22
WO2006029010A3 (en)	2006-09-08
WO2006029010A2 (en)	2006-03-16

Publication	Publication Date	Title
NL301145I2 (nl)	2021-12-07	Tirbanibulin
DK1827441T3 (da)	2011-07-18	Kombinationer til behandling af sygdomme, som involverer celleproliferation
ATE464056T1 (de)	2010-04-15	Verfahren zur aktivierung von nkt-zellen
MY159971A (en)	2017-02-15	Multipotent/pluripotent cells and methods
DE602005026492D1 (de)	2011-04-07	Bipolarplatte für Brennstoffzelle
DE112005003074B8 (de)	2023-07-27	Brennstoffzellensystem
DK2921500T5 (da)	2024-10-14	Genetisk modificerede, humane, naturlige dræbercellelinjer
WO2005047524A3 (en)	2005-12-29	Compositions and methods for inducing cell dedifferentiation
WO2009126655A3 (en)	2010-01-14	Reprogramming a cell by inducing a pluripotent gene through use of a small molecule modulator
DK2151243T3 (da)	2013-01-28	Sædcelleopslemninger til sortering i X- eller Y-kromosombærende berigede po-pulationer
DE112005001162B8 (de)	2014-01-23	Brennstoffzellensystem
NO20064194L (no)	2006-11-16	Fremgangsmate for a modulere IL-23-aktivitet, beslektede reagenser
CY1111769T1 (el)	2015-10-07	Παρασκευη κυτταρων
DE602005019478D1 (de)	2010-04-01	Brennstoffzellensystem
EP1810357A4 (en)	2010-03-24	Electrochemical device
DE602005002407D1 (de)	2007-10-25	Brennstoffzellensystem
ATE540655T1 (de)	2012-01-15	Windel mit elastischer oberschicht
DE602005020227D1 (de)	2010-05-12	Brennstoffzellensystem
MX2007008136A (es)	2008-02-12	Metodo para invertir la resistencia multiple en celulas animales.
ATE500629T1 (de)	2011-03-15	Brennstoffzellensystem
IS8570A (is)	2006-11-20	Stoðfrumulaus framhaldsrækt stofnfrumna
UY29440A1 (es)	2006-10-02	Nuevos compuestos
EP2069791A4 (en)	2009-11-11	CELLULAR RECEPTOR FOR ANTIPROLIFERATIVE FACTOR
ATE556446T1 (de)	2012-05-15	Batterieanoden
PA8776101A1 (es)	2009-03-31	Actividad antitumoral de cci-779 en el carcinoma papilar de celulas renales